Cognition of apalutamide + ADT treatment responders versus non-responders.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Arun Azad, Marco Antonio Badillo, Alicia K. Morgans, Dana Rathkopf, Karie Runcie, Geoffrey Gotto, Axel Stuart Merseburger, Alex Dos Santos, Jingwei Li, Sukie Shopeju, Meenakshi Chatterjee, Rana Zia Ur Rehman, Daniel P. Sanchez, Bhavini Patel, Amitabha Bhaumik, Vasanth Thirugnanam, Yanran Huo, Ashita S. Batavia, Mark A. Wildgust, Neeraj Agarwal
Institutions: Peter MacCallum Cancer Centre, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Columbia University Irving Medical Center, University of Calgary, University Hospital Schleswig-Holstein, Johnson & Johnson (United States), Johnson & Johnson (Germany), Johnson & Johnson (United Kingdom), Johnson & Johnson (Australia), University of Utah, Huntsman Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Johnson and Johnson
OpenAlex ID: W7162495388
Cites:
Cited by:
Related to:
